Furthermore, exogenous administration of recombinant human TRX significantly improved the survival rate and attenuated the histological changes in lungs in a mouse model of influenza pneumonia by diminishing the production of TNF-α and CXCL1 in the lungs observed in influenza-inoculated mice [33]. The gene discussed is CXCL1; the disease is influenza.